|
Volumn 37, Issue 13, 2001, Pages 1609-1616
|
Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: Results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia
|
Author keywords
High risk; Local failure free survival; Overall survival; Regional hyperthermia (RHT); Soft tissue sarcoma; Thermochemotherapy
|
Indexed keywords
DOXORUBICIN;
ETOPOSIDE;
IFOSFAMIDE;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
BEAM THERAPY;
CANCER CONTROL;
CANCER RECURRENCE;
CANCER RISK;
CANCER STATISTICS;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
HUMAN;
HYPERTHERMIC THERAPY;
MAJOR CLINICAL STUDY;
MALE;
METASTASIS;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SOFT TISSUE SARCOMA;
TREATMENT FAILURE;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, ADJUVANT;
COHORT STUDIES;
DISEASE-FREE SURVIVAL;
DOXORUBICIN;
ETOPOSIDE;
FEMALE;
HUMANS;
HYPERTHERMIA, INDUCED;
IFOSFAMIDE;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
PILOT PROJECTS;
PROSPECTIVE STUDIES;
RADIOTHERAPY, ADJUVANT;
RISK FACTORS;
SARCOMA;
TREATMENT OUTCOME;
|
EID: 0034880295
PISSN: 09598049
EISSN: None
Source Type: Journal
DOI: 10.1016/S0959-8049(01)00191-5 Document Type: Conference Paper |
Times cited : (47)
|
References (30)
|